title: Major treatment considerations for attention-deficit hyperactivity disorder.
authors.affiliation: Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Safer
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008774:Methylphenidate; D003913:Dextroamphetamine